Alabama–Zambia HIV clinical team
A-Z Clinical Trials Unit
['FUNDING_OTHER'] · UNIVERSITY OF ALABAMA AT BIRMINGHAM · NIH-11237054
A partnership between Alabama and Zambia that runs NIH-funded HIV clinical trials where people living with or at risk for HIV can join to try new prevention and treatment options.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIVERSITY OF ALABAMA AT BIRMINGHAM (nih funded) |
| Locations | 1 site (BIRMINGHAM, UNITED STATES) |
| Trial ID | NIH-11237054 on ClinicalTrials.gov |
What this research studies
This program links the University of Alabama at Birmingham with the Centre for Infectious Diseases Research in Zambia to run HIV clinical trials at two clinic sites. The team has enrolled over 1,000 participants across many network trials and manages participant visits, labs, pharmacies, data, and community engagement. Their work supports trials from major NIH networks (HVTN, HPTN, ACTG) and focuses on enrolling and keeping participants in studies while following strict quality and regulatory standards. If you join, the sites will collect medical information, samples, and follow-up data as part of specific trials they run.
Who could benefit from this research
Good fit: Ideal candidates are people living with HIV or people at risk for HIV who live near the participating clinics and meet the eligibility for a specific network trial.
Not a fit: People who do not meet individual trial eligibility criteria or who live far from the Alabama or Zambia clinic sites are unlikely to be able to participate or benefit directly.
Why it matters
Potential benefit: If successful, the trials run by this unit could lead to better HIV prevention and treatment options for people in the U.S. and Zambia.
How similar studies have performed: Other NIH network clinical trial units using this model have led to important HIV prevention and treatment advances, so the approach is well established.
Where this research is happening
BIRMINGHAM, UNITED STATES
- UNIVERSITY OF ALABAMA AT BIRMINGHAM — BIRMINGHAM, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: GOEPFERT, PAUL A. — UNIVERSITY OF ALABAMA AT BIRMINGHAM
- Study coordinator: GOEPFERT, PAUL A.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Acquired Immune Deficiency Syndrome, Acquired Immune Deficiency Syndrome Virus, Acquired Immunodeficiency Syndrome